-
1دورية أكاديمية
المؤلفون: Czira A, Requena G, Banks V, Wood R, Tritton T, Castillo CM, Yeap J, Wild R, Compton C, Rothnie KJ, Herth F, Quint JK, Ismaila AS
المصدر: International Journal of COPD, Vol Volume 18, Pp 643-659 (2023)
مصطلحات موضوعية: adherence, comparative effectiveness, chronic obstructive pulmonary disease (copd) treatment, inhaled corticosteroid/long-acting β2-agonist (ics/laba) dual therapy, long-acting muscarinic antagonist (lama)/laba dual therapy, Diseases of the respiratory system, RC705-779
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Singer D, Bengtson LG, Elliott C, Buikema AR, Franchino-Elder J
المصدر: International Journal of COPD, Vol Volume 15, Pp 3239-3250 (2020)
مصطلحات موضوعية: chronic obstructive pulmonary disease (copd), long-acting muscarinic antagonist (lama), soft mist inhaler (smi), dry powder inhaler (dpi), healthcare resource utilization, readmissions, exacerbations, Diseases of the respiratory system, RC705-779
وصف الملف: electronic resource
-
3دورية أكاديمية
المؤلفون: Gary T. Ferguson, Nicola Brown, Chris Compton, Thomas C. Corbridge, Kelly Dorais, Charles Fogarty, Catherine Harvey, Morrys C. Kaisermann, David A. Lipson, Neil Martin, Frank Sciurba, Marjorie Stiegler, Chang-Qing Zhu, David Bernstein
المصدر: Respiratory Research, Vol 21, Iss 1, Pp 1-15 (2020)
مصطلحات موضوعية: Triple therapy, COPD, Lung function, Symptoms, Long-acting β2-agonist (LABA), Long-acting muscarinic antagonist (LAMA), Diseases of the respiratory system, RC705-779
وصف الملف: electronic resource
العلاقة: http://link.springer.com/article/10.1186/s12931-020-01360-wTest; https://doaj.org/toc/1465-993XTest
-
4
المؤلفون: Yoshinobu Saito, Masahiro Seike, Takeru Kashiwada, Akihiko Gemma, Mizuki Yuasa, Namiko Taniuchi, Yosuke Tanaka, Tohru Tanaka, Mitsunori Hino
المصدر: Cureus
مصطلحات موضوعية: Agonist, long-acting muscarinic antagonist (lama), Pulmonology, inhaled corticosteroid (ics), medicine.drug_class, business.industry, General Engineering, Pulmonary disease, Muscarinic antagonist, long-acting beta 2 agonist (laba), Pharmacology, respiratory tract diseases, chronic obstructive pulmonary disease, Long acting beta, Long acting, airway resistance, impulse oscillation system (ios), medicine, Internal Medicine, Corticosteroid, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dca91952f62f7dc1dc7dfa43147bef9cTest
https://pubmed.ncbi.nlm.nih.gov/34873511Test -
5دورية أكاديمية
المؤلفون: Akihiko TANAKA, Hironori SAGARA, Koichi ANDO, Shin INOUE, Sojiro KUSUMOTO, Tohru OHMORI, Toshimitsu YAMAOKA, Tsukasa OHNISHI
المصدر: The Showa University Journal of Medical Sciences. 2018, 30(2):159
-
6دورية أكاديمية
-
7دورية أكاديمية
المؤلفون: Papi, Alberto, Petruzzelli, Stefano, Vezzoli, Stefano, Georges, George, Fabbri, Leonardo M.
المساهمون: Papi, Alberto, Petruzzelli, Stefano, Vezzoli, Stefano, Georges, George, Fabbri, Leonardo M.
مصطلحات موضوعية: Severe COPD, exacerbation, long-acting muscarinic antagonist (LAMA), long-acting β2-agonist (LABA), inhaled corticosteroid (ICS)
وصف الملف: STAMPA
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31000665; info:eu-repo/semantics/altIdentifier/wos/WOS:000464992000023; volume:53; issue:4; firstpage:1900147-1; lastpage:1900147-3; numberofpages:3; journal:EUROPEAN RESPIRATORY JOURNAL; http://hdl.handle.net/11392/2404119Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85065014933; https://erj.ersjournals.com/content/53/4/1900147Test
الإتاحة: https://doi.org/10.1183/13993003.00147-2019Test
http://hdl.handle.net/11392/2404119Test
https://erj.ersjournals.com/content/53/4/1900147Test -
8
المساهمون: Calzetta, Luigino, Rogliani, Paola, Matera, Maria Gabriella, Cazzola, Mario
المصدر: Chest. 149(5)
مصطلحات موضوعية: Pulmonary and Respiratory Medicine, medicine.medical_specialty, Settore MED/10 - Malattie dell'Apparato Respiratorio, Fixed-dose combination, Muscarinic Antagonists, Critical Care and Intensive Care Medicine, law.invention, 03 medical and health sciences, chemistry.chemical_compound, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Randomized controlled trial, Long-acting b2-agonist (LABA), law, Internal medicine, COPD, combination therapy, long-acting muscarinic antagonist (LAMA), long-acting β2-agonist (LABA), Administration, Inhalation, medicine, Humans, 030212 general & internal medicine, Combination therapy, Adrenergic beta-2 Receptor Agonists, biology, business.industry, Olodaterol, Lama, biology.organism_classification, medicine.disease, Dry-powder inhaler, Bronchodilator Agents, Dual bronchodilation, Long-acting muscarinic antagonist (LAMA), Treatment Outcome, 030228 respiratory system, chemistry, Meta-analysis, Physical therapy, Drug Therapy, Combination, business, Cardiology and Cardiovascular Medicine, hormones, hormone substitutes, and hormone antagonists
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe98c3d173850aa309f1708c76682901Test
https://pubmed.ncbi.nlm.nih.gov/29406771Test -
9
المصدر: European Respiratory Journal. 53:1900147
مصطلحات موضوعية: Pulmonary and Respiratory Medicine, medicine.medical_specialty, Exacerbation, MEDLINE, Socio-culturale, 03 medical and health sciences, 0302 clinical medicine, exacerbations, Internal medicine, medicine, 030212 general & internal medicine, long-acting muscarinic antagonist (LAMA), Asthma, COPD, biology, business.industry, Severe COPD, long-acting β2-agonist (LABA), inhaled corticosteroid (ICS), Lama, medicine.disease, Precision medicine, biology.organism_classification, respiratory tract diseases, Increased risk, 030228 respiratory system, Bronchodilator Agents, business, hormones, hormone substitutes, and hormone antagonists
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cd701359424e9cec04747dbd023b9f8Test
https://doi.org/10.1183/13993003.00147-2019Test -
10
المؤلفون: M.K. Siddiqui, Mousumi Biswas, Mario Ouwens, Pragya Shukla, Deniz Guranlioglu, Patrick Darken, Martin Jenkins
المصدر: Therapeutic Advances in Respiratory Disease
مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Agonist, medicine.drug_class, Network Meta-Analysis, Fixed-dose combination, Muscarinic Antagonists, Pharmacology, chronic obstructive pulmonary disease, Pulmonary Disease, Chronic Obstructive, 03 medical and health sciences, 0302 clinical medicine, Formoterol Fumarate, Administration, Inhalation, medicine, Humans, Pharmacology (medical), Metered Dose Inhalers, 030212 general & internal medicine, long-acting muscarinic antagonist (LAMA), Adrenergic beta-2 Receptor Agonists, Glycopyrrolate, Randomized Controlled Trials as Topic, COPD, business.industry, Muscarinic antagonist, medicine.disease, Metered-dose inhaler, fixed-dose combination, Drug Combinations, 030228 respiratory system, Meta-analysis, glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI), long-acting β2-agonist (LABA), business, Meta-Analysis, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1c9faf5c1c67af954183318e5d28bd0Test
https://doi.org/10.1177/1753466619894502Test